These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2405248

  • 1. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats.
    Riddick DS, Park SS, Gelboin HV, Marks GS.
    Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248
    [Abstract] [Full Text] [Related]

  • 2. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
    Riddick DS, Park SS, Gelboin HV, Marks GS.
    Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472
    [Abstract] [Full Text] [Related]

  • 3. Irreversible binding of heme to microsomal protein during inactivation of cytochrome P450 by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine.
    Riddick DS, Marks GS.
    Biochem Pharmacol; 1990 Oct 15; 40(8):1915-21. PubMed ID: 2242024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
    McNamee JP, Kimmett SM, Marks GS.
    Biochem Pharmacol; 1995 May 17; 49(10):1443-52. PubMed ID: 7763287
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents.
    McCluskey SA, Riddick DS, Mackie JE, Kimmett SM, Whitney RA, Marks GS.
    Can J Physiol Pharmacol; 1992 Aug 17; 70(8):1069-74. PubMed ID: 1473038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
    McCluskey SA, Marks GS, Whitney RA, Ortiz de Montellano PR.
    Mol Pharmacol; 1988 Jul 17; 34(1):80-6. PubMed ID: 3393143
    [Abstract] [Full Text] [Related]

  • 10. Cytochrome P-450 b and c in the rat brain and pituitary gland.
    Näslund BM, Glaumann H, Warner M, Gustafsson JA, Hansson T.
    Mol Pharmacol; 1988 Jan 17; 33(1):31-7. PubMed ID: 3275864
    [Abstract] [Full Text] [Related]

  • 11. Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts.
    Correia MA, Decker C, Sugiyama K, Caldera P, Bornheim L, Wrighton SA, Rettie AE, Trager WF.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):436-51. PubMed ID: 3674884
    [Abstract] [Full Text] [Related]

  • 12. 3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6.
    Riddick DS, Mackie JE, Massey TE, Marks GS.
    Can J Physiol Pharmacol; 1990 Mar 01; 68(3):370-3. PubMed ID: 2322893
    [Abstract] [Full Text] [Related]

  • 13. Mechanism-based inactivation of hepatic cytochrome P450 2C6 and P450 3A1 following in vivo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine to rats: differences from previously observed in vitro results.
    Kimmett SM, McNamee JP, Marks GS.
    Can J Physiol Pharmacol; 1994 Apr 01; 72(4):397-401. PubMed ID: 7922872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
    Kelley M, Hantelle P, Safe S, Levin W, Thomas PE.
    Mol Pharmacol; 1987 Aug 01; 32(1):206-11. PubMed ID: 3302669
    [Abstract] [Full Text] [Related]

  • 16. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC, Hilliard JB, Wong DD, Chambers MA, Park SS, Gelboin HV, Gerber N.
    J Pharmacol Exp Ther; 1990 Aug 01; 254(2):720-31. PubMed ID: 2117068
    [Abstract] [Full Text] [Related]

  • 17. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
    Prough RA, Brown MI, Dannan GA, Guengerich FP.
    Cancer Res; 1984 Feb 01; 44(2):543-8. PubMed ID: 6692359
    [Abstract] [Full Text] [Related]

  • 18. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T, Halpert J, Glaumann H, Gustafsson JA.
    Cancer Res; 1983 Nov 01; 43(11):5131-7. PubMed ID: 6413054
    [Abstract] [Full Text] [Related]

  • 19. Olfactory cytochrome P-450. Studies with suicide substrates of the haemoprotein.
    Reed CJ, Lock EA, De Matteis F.
    Biochem J; 1988 Jul 15; 253(2):569-76. PubMed ID: 3263118
    [Abstract] [Full Text] [Related]

  • 20. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
    Miller NE, Halpert JR.
    Drug Metab Dispos; 1987 Jul 15; 15(6):846-51. PubMed ID: 2893712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.